medigraphic.com
Boletín Médico del Hospital Infantil de México

2006, Number 1

<< Back Next >>

Bol Med Hosp Infant Mex 2006; 63 (1)

Multiple sclerosis in children at Hospital Infantil de Mexico Federico Gomez: an 11 year experience.

Lyncet-Mejorado D, Barragán-Pérez E

Language: Spanish
References: 25
Page: 40-46
PDF size: 94.90 Kb.


ABSTRACT

Introduction. Multiple sclerosis (MS) is a disorder characterized by a demyelinating, autoimmune and inflammatory process of the nervous system. MS in childhood, like in adults, is believed to involve a complex interaction between environmental triggers (such as infections), genetic predisposition, and an abnormal autoimmune response. Because multiple sclerosis is not common in children, diagnosis represents a great challenge. For this reason, a better understanding of the pathophysiology of MS and the advent of new imaging techniques have helped to improve earlier diagnosis and treatment.Objective: describe patients with MS attended in the Hospital Infantil de Mexico in the period between 1994 and 2005.
Material and methods. A retrospective study in patients with MS of both genders, between 2-15 years of age, evaluating the clinical symptoms, laboratory and imaging studies and the evolution of the disease.
Results. A total of 10 patients (9 females) were evaluated with starting symptoms at 11 years of age. The most salient clinical manifestations were headache, visual disorders and hemiparesis. The visual evoked potentials were abnormal in all children. The MRI studies showed abnormalities including hypodense regions in several areas of the brain. All the patients reported relapses with multiple neurological manifestations, the most common were hemiparesia and loss of visual acuity.
Conclusions. MS was once considered to be a rare disease in childhood. Nowadays, the recognition of pediatric MS is increasing. Early diagnosis may permit the initiation of treatment for acute attacks, relapses and progression of the disease.


REFERENCES

  1. McFarlin DE, McFarland HF. Multiple sclerosis. N Engl J Med. 1982; 307: 1183-7.

  2. Duquette P, Murray J, Pleines J, Ebers C, et al. Multiple sclerosis in childhood: Clinical profile in 125 patients. J Pediatr. 1987; 111: 359-63.

  3. Ruggieri M, Polizzi A, Pavone L, et al. Multiple sclerosis in children under 6 years of age. Neurology. 1999; 53: 478-84.

  4. Hauser SL, Fleischnick E, Weiner HL, Marcus D, et al. Extended major histocompatibility complex haplotypes in patients with multiple sclerosis. Neurology. 1989; 39: 275-7.

  5. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker NG. Multiple sclerosis. N Engl J Med. 2000; 343: 938-52.

  6. Alter M, Zhen-xin Z, Davanipour Z, et al. Multiple sclerosis and childhood infections. Neurology. 1986; 36: 1386-9.

  7. Facchini SA, Harding SA, Waldron II RL. Human immunodeficiency virus-1 infection and multiple sclerosis-like illness in a child. Pediatr Neurol. 2002; 26: 231-5.

  8. Roach ES. Is multiple sclerosis an autoimmune disorder? Arch Neurol. 2004; 61: 1615-6.

  9. Chaudhuri A, Behan PO. Multiple sclerosis is not an autoimmune disease. Arch Neurol. 2004; 61: 1610-2.

  10. Rose AS, Ellison GW, Myers LW, Tourtellotte WW. Criteria for the clinical diagnosis of multiples sclerosis. Neurology. 1976; 26: 20-2.

  11. Lublin FD. The diagnosis of multiple sclerosis. Curr Opin Neurol. 2002; 15: 253-6.

  12. Fazekas F, Barkhof F, Filippi M, Grossman RI, et al. The contribution of magnetic resonance imaging to the diagnosis of multiple sclerosis. Neurology. 1999; 53: 448-56.

  13. Golden GS, Woody RC. The role of nuclear magnetic resonance imaging in the diagnosis of MS in childhood. Neurology. 1987; 37: 689-93.

  14. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol. 1983; 13: 227-31.

  15. Mc Donald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol. 2001; 50: 121-7.

  16. Pohl D, Rostasy K, Reiber A, Hanefeld F. CFS characteristic in early-onset multiple sclerosis. Neurology. 2004; 63: 1966-7.

  17. Paty DW, Oger JF, Kastrukoff LF, Hashimoto SA, et al. MRI in diagnosis of MS: A prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT. Neurology. 1988; 38: 180-5.

  18. Gronseth GS, Ashman EJ. Practice parameter: The usefulness of evoked potentials in identifying clinically silent lesions in patients with suspected multiple sclerosis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2000; 54: 1720-5.

  19. Frohman EM. Multiple sclerosis. Med Clin North Am. 2003; 87: 867-97.

  20. Jones CT. Childhood autoimmune neurologic diseases of the central nervous system. Neurol Clin North Am. 2003; 21: 745-64.

  21. Visudhiphan P, Chiemchanya S, Santadusit S. Optic neuritis in children: Recurrence and subsequent development of multiple sclerosis. Pediatr Neurol. 1995; 13: 293-5.

  22. Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: Results of an international survey. Neurology. 1996; 46: 907-11.

  23. Mikaeloff Y, Moreau T, Debouviere M, et al. Interferonbeta treatment in patients with childhood-onset multiple sclerosis. J Pediatr. 2001; 139: 443-6.

  24. Gall JC, Hayles AB, Siekert RG, Keith HM. Multiple sclerosis in children. Pediatrics. 1958; 21: 703-9.

  25. Adams AB, Tyor WR, Holden KR. Interferon beta-1b and childhood multiple sclerosis. Pediatr Neurol. 1992; 21: 481-3.




2020     |     www.medigraphic.com